Juli Wu, PhD
Senior Program Administrator, Research Development (RD) and Team Building
SC CTSI Role
Dr. Wu is the Senior Research Development and Team Building Administrator for the Research Development Core at the SC CTSI. Dr. Wu manages team-building, science of team science, pilots and other research development efforts. She is the driver of novel and established approaches to collaboration and team science. Dr. Wu also manages the SC CTSI pilot funding program and helps funded research investigators advance into their next level of research and/or career development. Dr. Wu provides research development consultations for all faculty who are interested in applying for SC CTSI pilot funding or in facilitating and developing team-based research.
Before joining the SC CTSI research development core in 2017, Dr. Wu was Assistant Professor of Research at the Keck School of Medicine for 7 years. She brought to SC CTSI her extensive experience in biomedical research and knowledge of foundation and federal grant application and management. Dr. Wu has practical experience working with multi-institutional and multi-disciplinary research teams, both in research and in administration. She is also experienced in mentoring undergraduate and graduate students in the laboratory. As a research faculty, Dr. Wu focused her studies on the neurodevelopmental role of Met receptor tyrosine kinase, a gene most well-known for its role in cancer metastasis. She was also involved in a large NIMH-funded Silvio O. Conte Center, studying the influence of placental serotonin on neural development and behavior and served as co-Director of the Conte Center NeuroAnatomy core. Prior to joining USC as faculty, Dr. Wu was Assistant Director of the Beta Cell Biology Consortium Coordinating Center, an NIDDK-funded multi-disciplinary consortium with investigators from research institutes in the US, Europe, and Middle East.
Dr. Wu obtained her PhD from the Irell & Manella Graduate School of Biological Sciences at City of Hope studying the redox regulation of p53, a tumor suppressor protein. She then completed postdoctoral fellowships at the University of California Irvine and at the Vanderbilt University Medical School. During her postdoctoral studies, she switched her research goals from understanding the mechanisms of malignancy growth to deciphering the mechanisms of normal tissue development. Prior to obtaining her PhD degree, Dr. Wu earned a Master degree in Microbiology from California State University, Los Angeles, where she later went back as a visiting lecturer teaching Introductory Biochemistry.